Chronix closes in on $1.7M for chronic disease diagnosis
Chronix Biomedical, maker of various products used to detect and diagnose chronic diseases, has almost completed its $1.7 million round of equity, according to a filing with the SEC. Based in San Jose, Calif., the company is backed by Pentagram Partners and PrairieGold Venture Partners.
Next Story: Spore Islands launches on Facebook as EA tries social games expansion
Previous Story: Third quarter global game sales decline 6 percent
About the Author, Camille Ricketts
Camille was the lead writer for GreenBeat until August 2010. To reach VentureBeat's current writers, email tips@venturebeat.com.
VB Writers
Ben PopperEast Coast Editor
Dean TakahashiLead Writer, GamesBeat
Devindra HardawarNational Editor, MobileBeat Lead
Dylan TweneyExecutive Editor
ShoeEditor-in-Chief, GamesBeat
Heather KellySenior Editor
Jennifer Van GroveWriter
Jolie O'DellWriter
Matt MarshallFounder & Editor-in-Chief
Meghan KellyWriter
Sarah MitroffEditorial Assistant
Sean LudwigWriter
Sebastian HaleyReviews Editor, GamesBeat
Tom CheredarWriter
Ciara ByrneContributor
Julia PlevinContributor
Lindsey ComptonContributor
